Loading organizations...
Key people at Mytrus.
Mytrus was founded in 2009 by Manish Kothari (Co-founder, CEO & Board member).
Mytrus develops e-clinical technology focused on enhancing patient participation and data management within medical research. The company offers solutions for patient-centered electronic informed consent and robust data collection, streamlining the initial stages of clinical trials. Their core offerings leverage modern technologies to create a more accessible and efficient environment for both study participants and researchers.
The company was founded in 2009 by Carl Cummings, Steven Cummings, and Anthony. Their insight stemmed from the belief that contemporary technological advancements could fundamentally change how individuals safely and effectively engage with clinical research, addressing historical barriers to trial involvement. This vision shaped Mytrus's initial product development and strategic direction.
Mytrus’s products serve the clinical research community, particularly those seeking to improve the patient experience and data integrity in trials. The company's overarching mission is to transform the clinical trial patient journey, ensuring greater accessibility and engagement. This forward-looking approach aims to foster a more patient-centric model for medical innovation.
Key people at Mytrus.
Mytrus was founded in 2009 by Manish Kothari (Co-founder, CEO & Board member).
High-level overview
Myrtus (operating as Myrtus Venture) is an early-stage venture firm based in Paris that backs and supports startups across sectors using a hands‑on, data‑informed approach focused on growth and exits. The firm presents itself as sector‑agnostic but emphasizes technology and healthcare among its notable areas of activity and pursues early‑to‑growth stage investments with active operational support to portfolio companies[1][2].
Origin story
Myrtus Venture was founded in Paris (the profile lists its global HQ as Paris) as a diversified angel / venture vehicle that grew from experienced managers with prior deal and operator experience; the manager team claims execution of dozens of deals across tech and healthcare and several notable exits, which underpins the firm’s operator‑led strategy[1][2]. Publicly available profiles emphasize an evolution toward an explicitly data‑driven investment model and an emphasis on hands‑on support, but detailed founder biographies, exact founding year, and specific early traction items are not available in the cited listings[1][2]. (If you’d like, I can search for press releases, regulatory filings or team bios to provide founding year and partner names.)
Core differentiators
Role in the broader tech landscape
Quick take & future outlook
Myrtus appears positioned to continue backing early and growth‑stage startups across sectors, leveraging its operator experience and a data‑informed process to improve selection and portfolio outcomes[1][2]. Near‑term priorities likely include expanding deal flow (especially cross‑border European tech and healthcare opportunities), increasing AUM or launching subsequent funds, and demonstrating more public exits or flagship portfolio successes to raise the firm’s profile. The firm’s influence will grow if it can convert its claimed track record into visible marquee exits and publish more transparent team and fund metrics (vintage, AUM, realized multiples)—details that currently aren’t fully public in the sources cited[1][2].
If you want, I can:
Sources: Myrtus Venture firm profiles and summaries from VentureCapitalArchive and EU‑Startups profiles[1][2].